UPDATED Sep 03, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
300725 | CN¥42.57 | -1.6% | 61.5% | CN¥9.7b | CN¥47.00 | PE48.3x | E15.5% | 0.7% | ||
DHR | US$199.44 | -2.7% | -24.6% | US$145.9b | US$245.50 | PE41.8x | E15.5% | 0.6% | ||
ABOS | US$1.39 | 0% | -42.1% | US$82.4m | US$7.60 | PB0.7x | E15.4% | n/a | ||
301257 | CN¥46.50 | 28.2% | 84.6% | CN¥3.6b | CN¥27.51 | PE40.3x | E15.4% | 0.5% | ||
CMPS | US$4.71 | -0.2% | -30.6% | US$433.7m | US$14.90 | PB2.8x | E15.4% | n/a | ||
EYPT | US$12.00 | 1.4% | 43.5% | US$808.5m | US$34.42 | PS15.9x | E15.4% | n/a | ||
LAB B | Mex$22.42 | 0.2% | 16.0% | Mex$21.9b | Mex$29.50 | PE11.7x | E15.3% | 3.6% | ||
301301 | CN¥11.52 | -2.8% | 4.7% | CN¥25.9b | CN¥15.00 | PE23.6x | E15.2% | 2.3% | ||
RNTX | US$1.26 | 14.5% | -54.8% | US$31.5m | n/a | PB9.8x | E15.1% | n/a | ||
867 | HK$13.20 | 1.7% | 85.4% | HK$33.3b | HK$14.99 | PE17.7x | E15.0% | 2.2% | ||
600436 | CN¥202.93 | -1.3% | -0.5% | CN¥123.3b | CN¥243.16 | PE45.4x | E15.0% | 1.8% | ||
688131 | CN¥67.78 | 12.5% | 169.7% | CN¥15.0b | CN¥41.00 | PE50.8x | E15.0% | 0.3% | ||
AKUMS | ₹474.05 | -0.6% | -47.1% | ₹72.6b | ₹691.67 | PE21.3x | E14.9% | n/a | ||
AJANTPHARM | ₹2,557.50 | -0.8% | -20.8% | ₹319.4b | ₹3,008.33 | PE34.3x | E14.8% | 1.1% | ||
600276 | CN¥68.65 | 8.9% | 52.6% | CN¥479.5b | CN¥78.38 | PE61.9x | E14.8% | 0.3% | ||
SUNPHARMA | ₹1,578.70 | -1.3% | -13.9% | ₹3.8t | ₹1,930.16 | PE36.5x | E14.8% | 1.0% | ||
2410 | HK$14.39 | -7.3% | -44.0% | HK$5.5b | HK$24.01 | PS46777.8x | E14.8% | n/a | ||
3613 | HK$8.80 | -4.2% | 17.3% | HK$7.5b | HK$11.15 | PE14.3x | E14.7% | 4.0% | ||
OGN | US$9.83 | 6.8% | -55.8% | US$2.4b | US$13.17 | PE3.7x | E14.5% | 0.8% | ||
GPCR | US$19.71 | 3.7% | -48.0% | US$1.2b | US$73.08 | PB1.5x | E14.5% | n/a | ||
CASI | US$2.33 | 4.5% | -65.2% | US$35.6m | US$4.00 | PS1.1x | E14.5% | n/a | ||
RCKT | US$3.32 | 0% | -81.4% | US$349.6m | US$7.86 | PB1x | E14.5% | n/a | ||
2262 | CN¥24.34 | 0.5% | -6.8% | CN¥25.5b | CN¥28.99 | PE20.3x | E14.4% | 1.5% | ||
AZN | UK£122.10 | 2.8% | -6.4% | UK£189.3b | UK£136.49 | PE30.7x | E14.4% | 2.0% |